Core Viewpoint - The company has successfully achieved small-scale supply of its modified polymer materials business, which includes various types of modified plastics used in multiple industries [1] Group 1: Product Overview - The main products of the modified polymer materials business include modified polypropylene (PP), modified polystyrene (ABS), and modified engineering plastics, along with others such as modified PA6 and PEEK [1] - These products are primarily applied in sectors such as automotive parts, electronics, aerospace, defense, power and energy storage systems, charging stations, 5G, medical, and robotics [1] Group 2: Production Capacity - The company has established a pilot production base in Qingdao with an annual production capacity of 30,000 tons [1] - The modified materials business has commenced small-scale supply, although the products have not yet been utilized in low-altitude flying vehicles [1]

Group 1: Financial Performance - In 2024, the company achieved operating revenue of 67,885.20 million CNY, an increase of 18.59% year-on-year [3] - Revenue from products used in new energy vehicles reached 16,556.37 million CNY, up 126.21%, accounting for 24.39% of total revenue [3] - The net profit attributable to shareholders was 1,575.60 million CNY, a decrease of 32.34% compared to the previous year [3] Group 2: Order and Production Capacity - As of the end of 2024, the company had new injection mold orders worth 8.52 billion CNY, a year-on-year increase of 26.97% [5] - The company’s production capacity for molds in 2024 was approximately 1,000 sets, with an actual output of 735 sets, resulting in a capacity utilization rate of 73.5% [4] - By the end of 2024, the company had a backlog of injection mold orders worth 9.38 billion CNY, a 22.57% increase year-on-year [5] Group 3: Future Projects and Investments - The second phase of the Thailand factory is expected to be operational by August 2025, with an anticipated additional output value of around 100 million CNY [6] - The company plans to distribute cash dividends of 3 CNY per 10 shares, totaling 25,427,100 CNY, with a distribution ratio of 161.38% [6] - The company’s modified materials business is projected to reach a total capacity of 150,000 tons per year by the end of 2025 [12] Group 4: Research and Development - In 2024, the company invested 28,331.20 million CNY in R&D, accounting for 4.17% of operating revenue, a 15.34% increase year-on-year [10] - The company obtained a total of 29 patents in 2024, including 19 invention patents and 10 utility model patents [10] - The company has developed several core technologies, including micro-foaming injection molding technology and high-gloss PC+ABS plastic alloy technology [11][8] Group 5: Market Position and Strategy - The company maintains a strong order backlog and stable production operations, with a focus on sustainable development and shareholder returns [4][6] - The company’s foreign sales accounted for 60.97% of total revenue in 2024, with minimal impact from trade tensions due to a concentration of customers in Europe [13] - The company differentiates itself through a "molding and plastic integration" approach, providing comprehensive solutions from mold customization to raw material supply [15]

证券简称： 富恒新材 证券代码： 832469 深圳市富恒新材料股份有限公司 广东省深圳市宝安区燕罗街道罗田社区广田路 48-1 号 A 栋办公综合楼 深圳市富恒新材料股份有限公司招股说明书 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证券交易所主 要服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风险高等特点，投资者面 临较大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因 素，审慎作出投资决定。 保荐机构（主承销商） （上海市广东路 689 号） 1-1-1 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对注册申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自行负 责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担股票依法发行后因发 行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-2 声明 发行人及 ...

深圳市富恒新材料股份有限公司 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股票的法律 本次股票发行后拟在北京证券交易所上市，该市场具有较高的投资风险。北京证券交易所主 要服务创新型中小企业，上市公司具有经营风险高、业绩不稳定、退市风险高等特点，投资者面 临较大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因 保荐机构（主承销商） 素，审慎作出投资决定。 （上海市广东路 689 号） 1-1-1 证券简称： 富恒新材 证券代码： 832469 广东省深圳市宝安区燕罗街道罗田社区广田路 48-1 号 A 栋办公综合楼 深圳市富恒新材料股份有限公司招股说明书（申报稿） 效力，投资者应当以正式公告的招股说明书全文作为投资决定的依据。 中国证监会和北京证券交易所对本次发行所作的任何决定或意见，均不表明其对注册申 请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自行负 责； ...